Advertisement
Screener

EMBECTA CORP. (EMBC) Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net

2.8 / 5 stars · 68/120 Roast Me

EMBECTA CORP. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net

EMBECTA CORP. (EMBC) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of -$1.40 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2026-08-07

  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-06-30 was -$1.50M.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-03-31 was -$1.70M.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-12-31 was $1.80M, a 260.00% increase year-over-year.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-09-30 was $2.10M, a 61.11% decline year-over-year.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2025 was -$1.40M, a 104.98% decline from fiscal 2024.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2024 was $28.10M, a 74.53% increase from fiscal 2023.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2023 was $16.10M.
  • EMBECTA CORP. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2022 was -$7.10M.
Period endIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 monthIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 month as first filedIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 monthIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month as first filedIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 monthIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month as first filedIncrease (Decrease) in Other Noncurrent Assets and Liabilities, Net 12 month
2026-06-30-$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07
-$3.20M
derived: sum of 2 quarters · filed 2026-08-07
-$1.40M
10-Q · filed 2026-08-07
$700.00K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05
$100.00K
10-Q · filed 2026-05-05
$2.20M
derived: sum of 3 quarters · filed 2026-05-05
-$1.40M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$1.80M
10-Q · filed 2026-02-05
$3.90M
derived: sum of 2 quarters · filed 2026-02-05
$300.00K
derived: sum of 3 quarters · filed 2026-08-07
-$100.00K
derived: sum of 4 quarters · filed 2026-08-07
2025-09-30$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
-$1.50M
derived: sum of 2 quarters · filed 2026-08-07
-$1.90M
derived: sum of 3 quarters · filed 2026-08-07
-$1.40M
10-K · filed 2025-11-25
2025-06-30-$3.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07
-$4.00M
derived: sum of 2 quarters · filed 2026-08-07
-$3.50M
10-Q · filed 2026-08-07
$1.90M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05
$100.00K
10-Q · filed 2026-05-05
$5.50M
derived: sum of 3 quarters · filed 2026-05-05
$4.10M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$500.00K
10-Q · filed 2026-02-05
$5.90M
derived: sum of 2 quarters · filed 2026-02-05
$4.50M
derived: sum of 3 quarters · filed 2026-02-05
$19.30M
derived: sum of 4 quarters · filed 2026-02-05
2024-09-30$5.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
$4.00M
derived: sum of 2 quarters · filed 2025-11-25
$18.80M
derived: sum of 3 quarters · filed 2025-11-25
$28.10M
10-K · filed 2025-11-25
2024-06-30-$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08
$13.40M
derived: sum of 2 quarters · filed 2025-08-08
$22.70M
10-Q · filed 2025-08-08
$24.40M
derived: sum of 4 quarters · filed 2025-11-25
2024-03-31$14.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09
$24.10M
10-Q · filed 2025-05-09
$25.80M
derived: sum of 3 quarters · filed 2025-11-25
$34.70M
derived: sum of 4 quarters · filed 2025-11-25
2023-12-31$9.30M
10-Q · filed 2025-02-06
$11.00M
derived: sum of 2 quarters · filed 2025-11-25
$19.90M
derived: sum of 3 quarters · filed 2025-11-25
$25.10M
derived: sum of 4 quarters · filed 2025-11-25
2023-09-30$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25
$10.60M
derived: sum of 2 quarters · filed 2025-11-25
$15.80M
derived: sum of 3 quarters · filed 2025-11-25
$16.10M
10-K · filed 2025-11-25
2023-06-30$8.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09
$14.10M
derived: sum of 2 quarters · filed 2024-08-09
$14.40M
10-Q · filed 2024-08-09
$18.10M
10-Q · filed 2023-08-08
$15.00M
derived: sum of 4 quarters · filed 2024-12-11
2023-03-31$5.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09
$5.50M
10-Q · filed 2024-05-09
$8.10M
10-Q · filed 2023-05-12
$6.10M
derived: sum of 3 quarters · filed 2024-12-11
-$1.20M
derived: sum of 4 quarters · filed 2024-12-11
2022-12-31$300.00K
10-Q · filed 2024-02-09
$1.50M
10-Q · filed 2023-02-14
$900.00K
derived: sum of 2 quarters · filed 2024-12-11
-$6.40M
derived: sum of 3 quarters · filed 2024-12-11
-$6.80M
derived: sum of 4 quarters · filed 2024-12-11
2022-09-30$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11
-$6.70M
derived: sum of 2 quarters · filed 2024-12-11
-$7.10M
derived: sum of 3 quarters · filed 2024-12-11
-$7.10M
10-K · filed 2024-12-11
2022-06-30-$7.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08
-$7.70M
derived: sum of 2 quarters · filed 2023-08-08
-$7.70M
10-Q · filed 2023-08-08
2022-03-31-$400.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12
-$400.00K
10-Q · filed 2023-05-12
2021-12-31$0.00
10-Q · filed 2023-02-14
2021-09-30-$500.00K
10-K · filed 2023-11-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Orthofix Medical Inc. (OFIX)$0.373B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52